Modulation of left ventricular hypertrophy by dietary salt and inhibition of angiotensin converting enzyme

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Hypertension - Supplement

• Publication date

  1988-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004872-198812040-00042PMID 2853724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal alpha 2-adrenergic receptors and hypertension.

  1987cited by this paper
• Abnormal adrenal catecholamine synthesis in salt-sensitive Dahl rats.

  1987cited by this paper
• Role of sodium in hypertensive cardiac hypertrophy.

  1985cited by this paper
• The reversal of left ventricular hypertrophy with control of blood pressure in experimental hypertension.

  1984cited by this paper
• Cardiac status in juvenile borderline hypertension.

  1983cited by this paper
• Left ventricular hypertrophy and hypertension.

  1983cited by this paper
• The multifactorial role of catecholamines in hypertensive cardiac hypertrophy.

  1982cited by this paper
• Local modulation of adrenergic neuroeffector interaction in the blood vessel well.

  1981cited by this paper
• Effect of Converting Enzyme Inhibitor (SQ14,225) on Myocardial Hypertrophy in Spontaneously Hypertensive Rats

  1980cited by this paper
• A qualitative difference in plasma renin activity in dahl rats susceptible or resistant to salt-induced hypertension

  1980cited by this paper
• Cardiac Hypertrophy in Spontaneously Hypertensive Rats

  1974cited by this paper
• Possible Role of 18-Hydroxy-deoxy-corticosterone in Hypertension

  1972cited by this paper

• Targeting the Gut-Heart Axis Improves Cardiac Remodeling in a Clinical Scale Model of Cardiometabolic Syndrome

  2024cites this paper
• Sodium Intake and Target Organ Damage in Hypertension—An Update about the Role of a Real Villain

  2020cites this paper
• Lisinopril has a cardio-protective effect on experimental acute autoimmune myocarditis in rats.

  2017cites this paper
• Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

  2015cites this paper
• Blood pressure, magnesium and other mineral balance in two rat models of salt-sensitive, induced hypertension: effects of a non-peptide angiotensin II receptor type 1 antagonist.

  2014cites this paper
• with attenuated hypertrophic response in rats with myocardial infarction Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated

  2013cites this paper
• Age-dependent salt hypertension in Dahl rats: fifty years of research.

  2012cites this paper
• Target organ damage in hypertension: pathophysiology and implications for drug therapy.

  2006cites this paper
• Replacement of Alternative Improves ACE Regular Salt by a Novel Salt the Cardiovascular Effects Inhibitor Enalapril

  2006cites this paper
• University of Groningen Tissue ACE inhibition and sodium status in left ventricular dysfunction

  2005cites this paper
• Tissue ACE inhibition and sodium status in left ventricular dysfunction

  2005cites this paper
• Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction

  2004cites this paper
• Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats.

  2003cites this paper
• Prevention of Hypertension by Irbesartan in Dahl S Rats Relates to Central Angiotensin II Type 1 Receptor Blockade

  2001cites this paper
• INHIBITORY EFFECT OF NITRIC OXIDE ON THE RENIN–ANGIOTENSIN SYSTEM IN DAHL SALT‐SENSITIVE RATS

  1999cites this paper
• Lessons from rat models of hypertension: from Goldblatt to genetic engineering.

  1998cites this paper
• Effect of cilazapril and salt on Ca2+ extrusion in arterial smooth muscle of Dahl rats.

  1997cites this paper
• AT1 RECEPTOR ANTAGONIST, TCV 116, DOES NOT PREVENT CARDIAC HYPERTROPHY IN SALT‐LOADED DAHL SALT‐SENSITIVE RATS

  1996cites this paper
• Interrelationships between salt and fish oil in stroke-prone spontaneously hypertensive rat.

  1996cites this paper
• Effects of dietary salt and angiotensin-converting enzyme inhibitor on ATP-driven Ca pump and Na/Ca exchange in aortic rings of Dahl rats.

  1996cites this paper
• Replacement of Regular Salt by a Novel Salt Alternative Improves the Cardiovascular Effects of the ACE Inhibitor Enalapril

  1994cites this paper
• Cardiac hypertrophy and the blockade of angiotensin II receptors by losartan in salt-loaded Dahl salt-sensitive rats

  1994cites this paper
• Salt intake, blood pressure, and cardiovascular structure

  1994cites this paper
• Replacement of salt by a novel potassium‐ and magnesium‐enriched salt alternative improves the cardiovascular effects of ramipril

  1994cites this paper
• Role of vasopressin, the renin—angiotensin system and sex in Dahl salt-sensitive hypertension

  1993cites this paper
• Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats.

  1993cites this paper
• Regression of cardiovascular structural changes--a preventive strategy.

  1990cites this paper